Document is current
Any future updates will be listed below
-
Authors
Konig, Maximilian F. http://orcid.org/0000-0001-5045-5255
- License Information
-
More Information
Article History
First Online: 8 January 2024
Competing interests
: M.F.K. is a consultant to Argenx, Atara Biotherapeutics, Revel Pharmaceuticals, Sana Biotechnology and Sanofi. M.F.K. declares that he and The Johns Hopkins University have filed patent applications related to chimeric autoantigen-T cell receptor-T cell therapies and TCR region-targeting approaches.
